Regulatory innovations: why is the UK an attractive hub for CGT development?

“...the UK has representation in nearly 50% of all European ATMP trials” Jokūbas Leikauskas, Editor, BioInsights, speaks to Rehma Chandaria, Senior Regulatory Affairs Lead, Cell and Gene Therapy Catapult, about the UK’s position as an attractive hub for cell and gene therapy (CGT) development, recent Medicines and Healthcare products Regulatory Agency (MHRA) initiatives reshaping the regulatory framework, and the global implications of post-Brexit regulatory divergence.

Authors

Institutions

Publication Details

Journal
Cell and Gene Therapy Insights
Published
2025-02-13
DOI
https://doi.org/10.18609/cgti.2025.015
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulatory innovations: why is the UK an attractive hub for CGT development?

Rehma Chandaria
Cell and Gene Therapy Insights
Biomedical Ethics and Regulation
article

Regulatory innovations: why is the UK an attractive hub for CGT development?

Rehma Chandaria
article en

Abstract

“...the UK has representation in nearly 50% of all European ATMP trials” Jokūbas Leikauskas, Editor, BioInsights, speaks to Rehma Chandaria, Senior Regulatory Affairs Lead, Cell and Gene Therapy Catapult, about the UK’s position as an attractive hub for cell and gene therapy (CGT) development, recent Medicines and Healthcare products Regulatory Agency (MHRA) initiatives reshaping the regulatory framework, and the global implications of post-Brexit regulatory divergence.

Cell and Gene Therapy InsightsVol. 11(1)
Cell and Gene Therapy Catapult (GB)
Openalex Percentile: Top 50%
Biomedical Ethics and Regulation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Regulatory innovations: why is the UK an attractive hub for CGT development? — Rehma Chandaria · Cell and Gene Therapy Insights (2025) | TGRS Research Map | TGRS